Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 3, 2019
- Accepted in final form August 5, 2019
- First Published October 9, 2019.
Author Disclosures
- Clemens Küpper, MD,
- Johanna Heinrich, MD,
- Katharina Kamm, MD,
- Veit Bücklein, MD,
- Simon Rothenfusser, MD and
- Andreas Straube, MD
- Clemens Küpper, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Johanna Heinrich, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Katharina Kamm, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Veit Bücklein, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Simon Rothenfusser, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
BMBF/Helmholtz-Center Munich iMed/EKLIP
DFG. RO 2525/7-1, SFB-TR 237-14;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andreas Straube, MD
honoraria for advisory boards from Desitin (Germany), Allergan (Germany and Europe), electroCore (USA) and TEVA (Europe)
NONE
speaker fees from Desitin (Germany), Allergan (Germany), Pfizer (Germany), Hormosan (Germany) and MSD (Germany),
J of headache and ´pain (Springer) Der Schmerz (Springer)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
German scientific council (DFG), federal secretary of education (BMBF)and University of Munich
NONE
DMKG (German headache Society)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (C.K., J.H., K.K., A.S.), University Hospital, Ludwig Maximilians University; Laboratory for Leukemia Diagnostics (V.B.), Department of Medicine III, University Hospital, Ludwig Maximilians University; and Division of Clinical Pharmacology (S.R.), University Hospital, Ludwig Maximilians University, Munich, Germany.
- Correspondence
Dr. Küpper Clemens.Kuepper{at}med.uni-muenchen.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.